RSV infection - Not for kids only

New England Journal of Medicine

Volumn 352, Issue 17, 2005, Pages 1810-1812

  Sethi, Sanjay ^a   Murphy, Timothy F ^a  

^a NONE

Author keywords

[No Author keywords available]

Indexed keywords

ANTIVIRUS AGENT; INFLUENZA VACCINE; LIVE VACCINE; MONOCLONAL ANTIBODY; PALIVIZUMAB; RESPIRATORY SYNCYTIAL VIRUS VACCINE; RIBAVIRIN;

CLINICAL TRIAL; DIAGNOSTIC PROCEDURE; EDITORIAL; HIGH RISK POPULATION; HOSPITALIZATION; HUMAN; IMMUNE RESPONSE; IMMUNOFLUORESCENCE TEST; INFLUENZA; INFLUENZA VACCINATION; INFLUENZA VIRUS; MORTALITY; PRIORITY JOURNAL; RESPIRATORY SYNCYTIAL PNEUMOVIRUS; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; SEROLOGY; VIRUS CULTURE; VIRUS INFECTION;

ADULT; AGE FACTORS; AGED; HEART FAILURE, CONGESTIVE; HUMANS; INFLUENZA, HUMAN; PULMONARY DISEASE, CHRONIC OBSTRUCTIVE; RESPIRATORY SYNCYTIAL VIRUS INFECTIONS; RESPIRATORY SYNCYTIAL VIRUSES; RESPIRATORY TRACT INFECTIONS;

EID: 17644421801     PISSN: 00284793     EISSN: None     Source Type: Journal    
DOI: 10.1056/NEJMe058036     Document Type: Editorial

References (12)

1. Falsey AR, Hennessey PA, Formica MA, Cox C, Walsh EE. Respiratory syncytial virus infection in elderly and high-risk adults. N Engl J Med 2005;352:1749-59.
2. Sethi S, Evans N, Grant BJB, Murphy TF. New strains of bacteria and exacerbations of chronic obstructive pulmonary disease. N Engl J Med 2002;347:465-71.
3. Wongsurakiat P, Maranetra KN, Wasi C, Kositanont U, Dejsomritrutai W, Charoenratanakul S. Acute respiratory illness in patients with COPD and the effectiveness of influenza vaccination: a randomized controlled study. Chest 2004;125:2011-20.
4. Rovida F, Percivalle E, Zavattoni M, et al. Monoclonal antibodies versus reverse transcription-PCR for detection of respiratory viruses in a patient population with respiratory tract infections admitted to hospital. J Med Virol 2005;75:336-47.
5. Seemungal T, Harper-Owen R, Bhowmik A, et al. Respiratory viruses, symptoms, and inflammatory markers in acute exacerbations and stable chronic obstructive pulmonary disease. Am J Respir Crit Care Med 2001;164:1618-23.
6. Borg I, Rohde G, Loseke S, et al. Evaluation of a quantitative real-time PCR for the detection of respiratory syncytial virus in pulmonary diseases. Eur Respir J 2003;21:944-51.
7. Madhi SA, Klugman KP. A role for Streptococcus pneumoniae in virus-associated pneumonia. Nat Med 2004;10:811-3.
8. Welliver RC. Respiratory syncytial virus infection: therapy and prevention. Paediatr Respir Rev 2004;5:Suppl A:S127-S133.
9. Maggon K, Barik S. New drugs and treatment for respiratory syncytial virus. Rev Med Virol 2004;14:149-68.
10. Fenton C, Scott LJ, Plosker GL. Palivizumab: a review of its use as prophylaxis for serious respiratory syncytial virus infection. Paediatr Drugs 2004;6:177-97.
11. Polack FP, Karron RA. The future of respiratory syncytial virus vaccine development. Pediatr Infect Dis J 2004;23:Suppl:S65-S73.
12. Durbin AP, Karron RA. Progress in the development of respiratory syncytial virus and parainfluenza virus vaccines. Clin Infect Dis 2003;37:1668-77.